ADIPOQ and hypertriglyceridemia: In our present study, the action of the adiponectin gene (ADIPOQ) promoter SNP −11391 G/A (rs17300539) has been demonstrated on the risk of metabolic syndrome presence, insulin resistance, hypertriglyceridemia, and low serum adiponectin levels in Caucasian patients with obesity.